healthcarenews

The report “Behavioral/Mental Health Software Market by Component (Service, Software), Delivery (Subscription, Ownership), Functionality (Clinical, Administrative, Financial), End User (Clinic, Hospital, Private Practice, Payer), and Region – Global Forecast to 2022″, The behavioral health software market is expected to reach USD 2.31 Billion by 2022 from USD 1.15 Billion in 2017, at a CAGR of 14.8%. The growth of the market is attributed to the increasing adoption of behavioral health software, availability of government funding, government initiatives to encourage EHR adoption in behavioral health organizations, favorable behavioral health reforms in the US, and high demand for mental health services amidst provider shortage.

Browse 255 Market Data Tables and 37 Figures spread through 222 Pages and in-depth TOC on “Behavioral/Mental Health Software Market by Component (Service, Software), Delivery (Subscription, Ownership), Functionality (Clinical, Administrative, Financial), End User (Clinic, Hospital, Private Practice, Payer), and Region – Global Forecast to 2022”https://www.marketsandmarkets.com/Market-Reports/behavioral-health-software-market-45953340.html
Early buyers will receive 10% customization on reports.

Support services expected to dominate the market in 2017

Based on component, the behavioral health software market is segmented into software and support services. In 2017, the support services segment is expected to account for the largest share of the behavioral health software market. The recurring requirement of support services (such as for software upgrades and maintenance) is the major factor supporting its growth.

Based on functionality, the clinical functionality segment is projected to grow at the highest CAGR during the forecast period.

By functionality, the behavioral health software market is segmented into clinical, financial, and administrative functionalities. The clinical functionality segment is expected to register the highest rate during the forecast period. High growth in the clinical functionality segment is attributed to the increasing government initiatives to boost adoption of this software by clinicians to provide quality care to their patients at lower costs.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45953340

North America to dominate the behavioral health software market

In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as growing number of people requiring behavioral health services, behavioral health reforms in the US, and government funding for behavioral health services in the region.

The behavioral health software market is highly competitive with the presence of several small and big players. Some of the players in the behavioral health software market include Advanced Data Systems (US), AdvancedMD (US), Cerner (US), Compulink (US), Core Solutions (US), Credible Behavioral Health (US), ICANotes (US), InSync Healthcare Solutions (US), iSalus Healthcare (US), Kareo (US), Meditab Software (US), Mentegram (US), Mindlinc (US), Netsmart (US), Nextgen Healthcare (US), NextStep Solutions (US), Nuesoft Technologies (US), Qualifacts (US), Raintree Systems (US), Sigmund Software (US), The Echo Group (US), TheraNest (US), Valant (US), Welligent (US), and WRS Health (US).

The report “Resuscitation Devices Market by Product (Defibrillator, Endotracheal & Tracheostomy Tube, Masks, Airways, Laryngoscopes, Resuscitators, Ventilators), Patient Type (Neonatal, Adult), End User (Hospital, Ambulance, ICU), Volume – Global Forecast to 2025″ The global resuscitation devices market is projected to reach USD 8.7 billion by 2025 from USD 6.9 billion in 2020, at a CAGR of 4.7% during the forecast period.

Browse 145 market data Tables and 36 Figures spread through 187 Pages and in-depth TOC on “Resuscitation Devices Market by Product (Defibrillator, Endotracheal & Tracheostomy Tube, Masks, Airways, Laryngoscopes, Resuscitators, Ventilators), Patient Type (Neonatal, Adult), End User (Hospital, Ambulance, ICU), Volume – Global Forecast to 2025″

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/resuscitation-device-market-36161641.html

The growth in the global resuscitation devices market is driven by the rising prevalence of target diseases, increasing demand for emergency care, growing focus on providing public-access defibrillators, high incidence of preterm births, and training & awareness programs on defibrillators. Also, emerging markets and the development of wearable defibrillators are expected to offer growth opportunities for players operating in this market.

Airway management devices segment accounted for the largest share of the resuscitation devices market in 2019

On the basis of product, the resuscitation devices market is segmented into external defibrillators, airway management devices, convective warming blankets, and other resuscitation devices. The airway management devices segment accounted for the largest share of this market in 2019, majorly due to the high prevalence of chronic respiratory diseases, increasing demand for emergency care, and the high incidence of preterm births.

Hospitals, ASCs, and cardiac centers segment accounted for the largest share of the resuscitation devices market, by end user, in 2019

Based on end user, the resuscitation devices market is segmented into hospitals, ambulatory surgical centers (ASCs), and cardiac centers; pre-hospital care centers; and other end users. Hospitals, ASCs, and cardiac centers were the largest end users of resuscitation devices in 2019. The launch of training programs to efficiently undertake and operate lifesaving defibrillation procedures, increasing number of donations with regard to the purchase/implementation of defibrillators, and growing number of trauma cases and road accidents across the globe are few of the major factors driving the growth of this end-user segment.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36161641

North America accounted for the largest share of the resuscitation devices market in 2019

In 2019, North America accounted for the largest share of the resuscitation devices market. The rising geriatric population, increasing incidence of cardiac and respiratory diseases, and continuous technological advancements and product innovations are the major factors driving the growth of the resuscitation devices market in North America. Also, increasing efforts by governments to provide the necessary care to cardiac arrest victims at public places through public-access defibrillation programs have increased the demand for emergency care in the region.

Leading Companies

Prominent players in the resuscitation devices market include Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), ZOLL Medical Corporation (US), ResMed, Inc. (US), Physio-Control (acquired by Stryker Corporation, US), Drägerwerk AG & CO. KGaA (Germany), Smiths Medical (US), Ambu (Denmark), Cardinal Health (US), Mindray Medical (China), Nihon Kohden (Japan), Teleflex (US), Salter Labs (US), GE Healthcare (US), Roper Technologies (US), Vyaire Medical (US), Intersurgical (UK), 3M (US), Flexicare (UK), and KARL STORZ (Germany).

The scope of the report includes patient monitoring devices for continuous monitoring, detection, and treatment of heart, brain, lungs, and blood activities and measurement of temperature and weight of the body. The base year considered for the study is 2017, and the forecast period for the study is between 2018 and 2023.

The patient monitoring devices market is projected to reach USD 25.31 billion by 2023 from USD 18.11 billion in 2017, at a CAGR of 5.7%.

Opportunity: Emerging markets

The healthcare industry in emerging countries (such as India, China, Brazil, and Mexico) will offer significant growth opportunities for patient monitoring device manufacturers owing to the increasing patient population across these countries, coupled with the rising adoption of patient monitoring devices in these countries.

Moreover, emerging countries have registered a sustained increase in the volume of surgical procedures during the past decade, driven by the growing target patient population, the presence of a supportive regulatory environment, and rising medical tourism. Therefore, emerging countries are expected to offer potential growth opportunities to players in the patient monitoring devices market during the forecast period.

Download PDF Brochure @ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=678

Challenge: Risks associated with invasive monitoring devices

There are several risks associated with the use of invasive monitoring systems, such as the discomfort associated with the insertion of monitoring instruments, such as pulmonary artery catheters (PAC). Air embolism, sepsis, bleeding/hematoma formation, cardiac arrhythmias, reduced circulation to the distal limb, hemorrhage, nerve damage (during insertion), thrombosis, air embolism, and pulmonary capillary necrosis are some major risks. These factors increase the mortality rate during invasive procedures.

In addition, the use of invasive monitoring systems is not recommended for elderly and weak patients. Due to the associated risks, invasive monitoring is recommended only for a set of specific indications, provided that the risks associated are overshadowed by benefits of obtaining the relevant data during the procedure. Moreover, invasive monitoring is extremely expensive and requires skilled professionals to perform catheter insertions in patients. Although invasive monitoring provides accurate, comprehensive, and continuous data about the state of patients, the above-mentioned risks limit its usage.

Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=678

Geographical Region Covered

In 2018, North America is expected to account for the largest market share, followed by Europe. Factors such as the rising geriatric population, the presence of advanced healthcare infrastructure, and high healthcare expenditure are supporting the growth of the patient monitoring devices market in North America.

Key Players

Nihon Kohden, Natus Medical, Koninklijke Philips N.V., Edward Lifesciences, Omron, Masimo, GE Healthcare, Hill-Rom Holdings, Drägerwerk AG, Compumedics, Shenzhen Mindray Bio-Medical Electronics

The report “Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) – Global Forecast to 2024″, is projected to reach USD 18.88 billion by 2024 from USD 10.30 billion in 2018, at a CAGR of 10.6%.

Growth in this market is mainly driven by the growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced & user-friendly products, and the increasing demand for aesthetic treatments among men.

Facial aesthetic products segment is estimated to hold the largest share of the medical aesthetics market in 2018

On the basis of products, the medical aesthetics market is segmented into facial aesthetic products (dermal fillers, botulinum toxin, microdermabrasion, and chemical peels); body contouring devices (nonsurgical fat reduction devices, cellulite reduction devices, and liposuction devices); cosmetic implants [breast implants (silicone implants and saline implants), facial implants, and other cosmetic implants]; hair removal devices (laser hair removal devices and IPL hair removal devices); skin aesthetic devices (laser resurfacing devices, nonsurgical skin tightening devices, micro-needling products, and light therapy devices); tattoo removal devices; thread lift products; physician-dispensed cosmeceuticals and skin lighteners; physician-dispensed eyelash products; and nail treatment laser devices.

The facial aesthetic products segment is estimated to account for the largest share of the medical aesthetics market in 2018. The large share of this segment is attributed to the growing patient demand for and willingness to undergo facial aesthetic treatments, increasing disposable income and spending capabilities, and the rising geriatric population across the globe.

Download PDF Brochures @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=885

Clinics, hospitals, and medical spas segment is estimated to be the fastest-growing end users in the medical aesthetics market during the forecast period

On the basis of end user, the medical aesthetics market is segmented into clinics, hospitals, and medical spas; beauty centers; and home care. The clinics, hospitals, and medical spas segment is estimated to hold the largest share of the global medical aesthetics market in 2018. This end-user segment is also estimated to be fastest-growing end-user segment during the forecast period with the CAGR of 10.8%, owing to the increasing number of clinics and medical spas and the high availability of financial and infrastructural resources with hospitals, including technologically advanced devices, trained staff, and skilled professionals to perform aesthetic procedures.

North America dominated the medical aesthetics market in 2018

Geographically, the medical aesthetics market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, India, South Korea, and the Rest of Asia Pacific), and the Rest of the World (Latin America, the Middle East, and Africa). North America is estimated to account for the largest share of the global medical aesthetics market in 2018. The large share of this region in the global market can be attributed to the growing procedural volume for aesthetic procedures and the high adoption rate of novel technologies in this region.

In 2018, the APAC medical aesthetics market is estimated to register the highest CAGR of 13.0% during the forecast period. The key factors influencing the growth of the APAC medical aesthetics market include rising consumer awareness and interest in aesthetic procedures, aggressive marketing by US and European companies, and rising medical tourism in the region.

Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=885

The report “Sports Medicine Market by Product (Body Reconstruction (Arthroscopy devices, Implants), Body Support & Recovery Products (Physiotherapy Equipment, Compression Clothing, Braces & Supports)), Application and Region – Global Forecasts to 2024″, is expected to reach USD 9.1 billion by 2024 from USD 6.6 billion in 2019, at a CAGR of 6.5%. Growth in the sports medicine market is mainly driven by factors such as the continuous influx of new products &s treatment modalities, the increasing incidence of sports injuries, and developments in the field of regenerative medicine.

The body reconstruction products segment is expected to account for the largest share of the sports medicine product market in 2019

On the basis of product, the sports medicine market is segmented into body reconstruction products (fracture & ligament repair products, arthroscopy devices, implants, prosthetics, orthobiologics), body support & recovery products (braces & support, physiotherapy equipment, and compression clothing), and accessories. The body reconstruction products segment held the largest share of the sports medicine market in 2018, while the body support & recovery products segment is projected to register the highest growth during the forecast period. The technological advancements in arthroscopic technologies worldwide and the increasing number of sports injuries are major factors driving market growth for body reconstruction products.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=751

Hip & groin injuries segment is expected to grow at the highest CAGR in the global sports medicine market during the forecast period

On the basis of application, the market is segmented into knee injuries, shoulder injuries, foot & ankle, elbow & wrist, back & spine, hip & groin, and other injuries. The knee injuries segment commanded the largest share of the market in 2018. However, the hip & groin injuries market is projected to register the highest CAGR owing to the increasing participation of high school and college athletes in sports.

North America is expected to dominate the sports medicine market during the forecast period

Geographically, North America is expected to dominate the global sports medicine market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the growth of the sports industry and overall participation in sports. Sporting events such as the 2008 Beijing Olympics, 2018 Winter Olympics in Korea, and the upcoming 2020 Summer Olympics in Japan have increased the level of interest in sports in Asia.

Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=751

Key Players

The major players operating in the sports medicine market include Arthrex, Inc (US), Smith & Nephew plc (UK), and Stryker Corporation (US). Other players involved in this market include Breg Inc. (US), DJO Global, Inc. (US), Mueller Sports, Inc. (US), Wright Medical Group N.V. (US), Medtronic (Ireland), RTI Surgical (US), Performance Health International Limited (US), KARL STORZ (Germany), and Bauerfeind AG (US).

The global Peripheral Vascular Devices Market was valued at USD 10.3 billion. It is expected to reach USD 14.3 billion by 2024, at a CAGR of 6.8%. The growth of this market is due to the rapid growth in the geriatric population, rising disease prevalence, and the growing preference for minimally invasive products. The demand for these products has also shown significant growth in emerging economies.

The atherectomy devices segment held the largest share in the plaque modification devices market in 2018

Based on type, the market for plaque modification devices is segmented into atherectomy devices and thrombectomy devices. Atherectomy devices held the leading share of the plaque modification devices market in 2018. This is driven largely by the increasing obesity levels worldwide and the increasing number of approvals for new products in this field.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790

Drug-eluting balloons will register the highest growth rate in the angioplasty balloons market

Based on type, angioplasty balloons are classified as old/normal, drug-eluting, and cutting and scoring balloons. Of these, drug-eluting balloons are expected to show the highest growth during 2018–2022, mainly due to the increasing demand for angioplasty procedures. This has ensured a greater focus on product availability and thereby stimulated the approval of new products in the market.

By region, North America formed the largest market segment in 2018

North America, Europe, the Asia Pacific, and the Rest of the World (RoW) are the key regional markets for peripheral vascular devices. Of these, North America held the largest market share in 2018, mainly due to the growing geriatric population, a strong base of industry players in the region, and the increasing prevalence of cardiovascular diseases.

Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=790

Leading Companies

The leading players in the market are Abbott Laboratories (US), Cardinal Health (US), Biosensors International Group (Singapore), Boston Scientific Corporation (US), iVascular (Spain), Becton, Dickinson and Company (US), Medtronic (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), and BIOTRONIK (Germany).

Growth in the global market is mainly driven by the increasing R&D spending, technological advancements in process development, growth in the biopharmaceutical industry, and growing pressure to lower the cost of manufacturing. However, factors such as the high cost of technology and equipment in this market and lack of adequate infrastructural facilities are restraining the growth of this market to a certain extent.

The global high throughput process development market is expected to reach USD 415.5 Million in 2021 from USD 162.9 Million in 2015, at a CAGR of 14.4% during the forecast period.

Based on technology, the market is categorized into chromatography, ultraviolet-visible spectroscopy, and others (ELISA, chip electrophoresis, SPR, and qPCR). The chromatography segment accounted for the largest share of the global market in 2016. The chromatography segment is further divided into ion exchange chromatography (IEC), affinity chromatography (AC), multimodal chromatography (MC), and others (hydrophobic charge induction chromatography (HCIC) and size exclusion chromatography).

The affinity chromatography segment accounted for the largest share of the chromatography high throughput process development in 2016. Owing to the advantages of affinity chromatography over other chromatography such as high selectivity, high flow rate and its capacity for extensive removal of process-related impurities such as host cell proteins, DNA, and Cell Culture media component are driving the growth of the market.

Based on product and service, the market is categorized into consumables, instruments, services, and software. The consumables segment accounted for the largest share of the global high throughput process development market in 2016. The availability of a wide range of reagents and continuous product developments and innovations are expected to drive the HTPD consumables market.

Factors such as the high cost of technology and equipment in this market and the lack of adequate infrastructural facilities are restraining the growth of this market to a certain extent.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10249359

Geographical Region Covered

Geographically, North America (comprising the US and Canada) accounted for the largest share of the global market in 2016. Factors such as increasing R&D spending by pharmaceutical and biopharmaceutical companies, growing demand for technical tools for improving the production quality of biological materials, collective pressure towards lowering the cost of manufacturing biological materials, rising demand for reducing product development timelines, and the presence of major players in this region are driving the growth of the North American market.

Leading Companies

Major players operating in the high throughput process development market include Danaher (US), GE Healthcare (US), Agilent Technologies (US), Merck Millipore (Germany), and Thermo Fisher Scientific (US).

Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis.

The global respiratory drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period.

The respiratory drug delivery market by formulation segment is further divided into device type and formulation type. The types of respiratory drug delivery is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The dry powder inhalers segment is expected to witness the highest growth during the forecast period due to the advantages associated with the use of these inhalers, such as short administration & preparation time, ease of use, and fewer irritant effects.

The respiratory drug delivery market, based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles.

Based on applications, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other applications (cardiovascular disease, diabetes, respiratory therapy, and treatment of patients on ventilators). The asthma segment accounts for the major share in the market during the forecast period due to increasing prevalence of asthma across the globe.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=179682410

Geographical Region Covered

Currently, North America dominates the pulmonary drug delivery devices market, and Asia represents the second-largest regional market. Moreover, the Asian market is expected to register the highest CAGR during the forecast period due to the rapidly growing geriatric population, growing adoption of an unhealthy lifestyle, growing urbanization, exposure to smoke & chemicals, and the subsequent increase in the prevalence of COPD in the region.

Leading Companies

Prominent players in the respiratory drug delivery market include GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.).

Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients. This is an integral part of the blood management procedure in hospitals and blood banks centers.

The global blood collection market is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5% during forecast period.

The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products.

Increasing disease incidence and growing number of accidents & trauma cases

The prevalence of infectious diseases such as Human Papillomavirus (HPV), hepatitis, Human Immunodeficiency Virus (HIV), and tuberculosis are high despite significant improvements in sanitation and medicine. Traditionally, antimicrobial therapy was used as a powerful tool to combat infectious diseases; however, over the years, antimicrobial agents have failed to deliver the desired results due to the emergence of drug-resistant microbes. Owing to this, the prevalence of these infectious diseases is increasing globally. The prevalence of lifestyle diseases is also growing across the globe. This will be favorable for the market growth, as blood tests are a primary mode of diagnosing these diseases. An increase in the number of road accidents, fires, and sports injuries has led to the increased occurrence of trauma and injury cases.

According to a WHO Global Status Report on Road Safety, in 2013, road accidents were the eighth-leading cause of death worldwide. Current trends show that by 2030, road accidents will become the fifth-leading cause of death, globally. The National Trauma Institute has stated that trauma injuries accounted for 30% of life years lost (a measure to account for the age at which deaths occur) in the US in 2014.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39733117

Geographical Region Covered

North America is expected to account for the largest share of this market. Government initiatives for blood safety, increasing prevalence of lifestyle diseases, the presence of key players in the region, and increasing adoption of automated blood collection devices are the key growth drivers of the North American market.

Key Market Players

Becton, Dickinson and Company, Medtronic, Terumo Corporation, Haemonetics, Fresenius, Nipro Medical Corporation, F.L. Medical, Greiner Holding, Smiths Group, Grifols, Kawasumi Laboratories, Quest Diagnostics, Sarstedt, Retractable Technologies, Ab Medical.

According to a new market research report “Medical Holography Market by Product (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), End User (Medical Schools, Pharmaceutical Companies, Hospitals) – Global Forecast to 2021” published by MarketsandMarkets, The Global Medical Holography Market Is Projected to Reach USD 953.9 Million by 2021, at a CAGR of 33.7% from 2016 to 2021.

The growth in this market can be mainly attributed to the growing clinical applications of holography in the healthcare sector, rising adoption of holography products in biomedical research and medical education, and emergence of holography as a promising technology in representing complex 3D structures.

In this report, the global Medical Holography Market is segmented on the basis of product type, application, end user, and region. Based on product type, the market is segmented into holographic displays, holography microscopes, holographic prints, holography software and holoscopes. On the basis of application, the Medical Holography Market is segmented into three segments namely medical imaging, medical education, and biomedical research. While on the basis of end user, the Medical Holography Market is segmented into research laboratories, academic medical centers, pharmaceutical and biotechnology companies, and hospitals and clinics.

In 2015, the holographic displays product segment accounted for the largest share of the Medical Holography Market. This market is primarily driven by the increasing adoption of holographic displays in diagnostic imaging and for medical teaching and training as these displays provide high-quality real-time 3D images which attracts the user effectively.

Download PDF Brochures – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183930222

In 2015, North America represented the largest regional market, followed by Europe, Asia-Pacific, and the RoW. North America represents the fastest-growing region for the Medical Holography Market, primarily due to increasing research initiatives in holography technology, adoption of holographic products by research laboratories and academic centers, and increasing healthcare expenditure in the U.S.

The medical holography market in North America is expected to grow at the highest CAGR during the forecast period. Factors such as increasing demand for noninvasive and radiation-free imaging techniques coupled with the growing geriatric population and increasing number of imaging procedures across the region are driving the growth of regional market.

Know more about Medical Holography Market – https://www.marketsandmarkets.com/PressReleases/medical-holography.asp

The transition to ICD-10 coding standards from ICD-9 in North America, the growing demand for CAC solutions, the growing need within the global healthcare system to curtail increasing healthcare costs, improve coding accuracy, and streamline the revenue cycle management procedures.

The computer assisted coding market is expanding with the emergence of new products and applications. These computer assisted coding solutions being used in many applications such as automated computer-assisted encoding, management reporting & analytics, and clinical coding auditing.

Implementation of ICD-10 Drive the Global Computer Assisted Coding Market

Many hospitals, especially in North America, are adopting CAC systems to manage the increasing load of coding resulting from the adoption of ICD-10 standards. Major health plans like Medicare have reported a smooth transition to ICD-10 due to rigorous testing for over six years. The ICD-10 coding system requires the use of 72,000 procedure codes and 68,000 CM codes, as opposed to the 4,000 and 14,000 codes, respectively, in the ICD-9 system. The requirement of managing a high volume of codes in the ICD-10 system is in turn driving the demand for automation.

The US is expected to dominate the global CAC market due to the mandated switchover to ICD-10 coding standards in October 2015. This transition may result in a decline in coders’ productivity, thereby resulting in lower profitability for hospitals. The implementation of CAC systems can resolve this issue as they enable healthcare organizations to work more efficiently while complying with procedural coding standards as per ICD-10 guidelines. This trend is expected to provide a strong stimulus to the growth of the CAC market in North America in the coming years.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170644018

Geographical Region

The computer assisted coding market in APAC is expected to grow at the highest CAGR during the forecast period. The growth of this region is primarily driven by the escalating demand to reduce the burden of the healthcare systems, curtail healthcare delivery costs, increasing implementation of Healthcare IT solutions, and the various government initiatives for enabling efficient, affordable, and on-time delivery of quality care. As a result, APAC holds a significant share of the overall computer assisted coding market.

Leading Companies

3M Health Information Systems (US), Optum (US), McKesson Corporation (US), Nuance Communications (US), Cerner Corporation (US), Dolbey Systems (US), Precyse Solutions (nThrive) (US), Craneware (UK), Artificial Medical Intelligence (US), and TruCode (US). Other players include Quest Diagnostics (US), Streamline Health Solutions (US), M-scribe Technologies (US), eZDI Inc. (US), Alpha II LLC. (US), ID GmbH & Co. KGaA (Germany), ZyDoc (US), Coding Strategies (US), Patient Code Software (US), and Flash Code (US) among others.

Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=170644018

The global mice model market involves use of different varieties of mice (inbred, outbred, and conditioned/surgically modified, among others) in the research studies across the globe. Mice models are widely used as research models to study human genes and human diseases. Scientists use mice models to explore various health problems and assure the safety of new medical treatments.

Factors such as ongoing innovations in mice models, continuous support in the form of investments and grants, and growing demand for humanized mice models.

The mice model market is expected to reach USD 1.59 billion by 2021 from USD 1.11 billion in 2016, at a CAGR of 7.5% from 2016 to 2021.

On the basis of type, the mice model market is segmented into inbred mice, genetically engineered mice, conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, and spontaneous mutant mice. The knockout mice models is expected to grow at the highest CAGR during the forecast period. The high growth mice of knockout mice model can be attributed to the popularity of CRISPR Technology for creating gene knockouts, high investments in the development of new and innovative knockout models that also increases the application areas for these models.

On the basis of services, the mice model market is segmented into breeding, quarantine, rederivation, cryopreservation, genetic testing, model in-licensing, and other services such as surgical services, line rescue services, and in vivo pharmacology services. The breeding services segment is expected to command the largest share of the market. The large share of this segment can be attributed to the growing need for expertise in breeding mutant, transgenic, gene-targeted, and other types of mice, resulting in growth in demand for breeding services amongst biomedical and pharmaceutical researchers.

Download PDF Brochure @

 https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1308

On the basis of technology, the mice model market is segmented into CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (genetically modified sperm-mediated gene transfer, virus/vector-mediated gene transfer, liposome-mediated DNA transfer, electroporation of DNA, biolistics, and TALENs & ZFNs). The CRISPR segment accounted for the largest share of the mice model market in 2016. The large share of this segment is mainly attributed to the fact that CRISPR is the most widely used technique due to the various advantages associated with it, such as ease of design, high efficiency, and relatively low cost.

On the basis of therapeutic area, the mice model market is segmented into oncology studies, immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, diabetes studies, and other disease studies (mice models for rare diseases and metabolism & regulatory disorder studies, hematopoiesis, renal and toxicology studies). The oncology studies segment commanded the largest share of the mice model market in 2016. The large share of this segment can primarily be attributed to the growing cancer research activities and increasing innovation in mice models that are tailored to meet cancer research needs.

On the basis of mice care products, the mice model market is segmented into bedding, cages, feed, and other products such as gnotobiotic equipment, water systems, and accessories (washing systems, water purification systems, and sound absorption panels, among others). The cages product segment commanded the largest share of the mice model market in 2016.

Growing use of rat models, regulations & laws formulated for ethical use of animals and increased benefits offered by cryopreservation are the major factor restraining the growth of the market.  Various regulations and laws have been laid down by governments for ensuring ethical use of animals in research activities. Research institutes and companies carrying out studies on animals have to comply with these standards and requirements formulated for animal testing.

Request for Sample Pages @
 https://www.marketsandmarkets.com/requestsampleNew.asp?id=1308

Leading Companies 

The key players in the global mice model market include Charles River Laboratories International (US), The Jackson Laboratory (US), Taconic Biosciences (US), Envigo (UK), Laboratoratory Corporation of America Holdings (US), JANVIER LABS (France), Harbour BioMed (China), TRANS GENIC (Japan), genOway (France), and Horizon Discovery Group (US).

Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market.

The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6%.

Market is segmented into oral and parenteral routes of administration. The oral route of administration is expected to register the largest share and highest CAGR during the forecast period. This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route.

Market is segmented into osteoporosis, rickets, skin diseases, muscle weakness, autoimmune disorders, and other applications. The osteoporosis segment is expected to register the highest growth during the forecast period. This growth can be attributed to the increasing incidence of falls and fractures in senior adults due to the elevated levels of parathyroid hormones and the poor absorption of calcium from their diets.

Download PDF Brochure @ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32540026

Geographical Region

The vitamin D therapy market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The Asia Pacific dominated the market in 2018 and is expected to register the highest CAGR during the forecast period. Growth in the APAC is largely driven by the increasing awareness about vitamin D deficiency and supportive government policies and programs for the implementation of vitamin D deficiency treatment plans, heavy air pollution, sedentary lifestyles, increasing incidence of vitamin D deficiency, atypical diets, decreasing sun exposure, and rising malnutrition levels.

Key Market Players

Some of the prominent players in the market are Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd (India).

Abbott (US) is the largest player in the vitamin D therapy market. It has a strong foothold in the market. Abbott has a global distribution network and a good brand reputation among end users. The company’s strong presence and wide distribution channels across the globe have helped it to maintain its leading position in the market. In order to strengthen its position in the market, the company significantly invests in R&D activities. In 2018, the company invested USD 2.30 billion in R&D activities as compared to USD 2.26 billion in 2017.

Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=32540026

Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries.

The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3%.

Ligation devices market is segmented into handheld instruments and accessories. The accessories segment accounted for a share of 68.2% in 2018 and is anticipated to grow at a CAGR of 6.9% during the forecast period. This growth can be attributed to the increasing number of surgical procedures, especially in emerging markets.

Ligation devices market is segmented into gastrointestinal & abdominal surgeries, gynecological surgeries, cardiovascular surgeries, urological surgeries, and other applications such as wound, ENT, and cosmetic applications. The cardiovascular surgeries segment is anticipated to drive growth in the market at a CAGR of 6.9% over the forecast period. This growth can be attributed to the increase in the incidence of cardiovascular diseases. Additionally, with technological advancements in cardiovascular robotic surgery, the demand for ligation devices is anticipated to increase.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22007372

Geographical Region 

The ligation devices market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). While North America dominated the market in 2018, Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC region is largely driven by the large patient population and increasing infrastructural development in the region.

Leading Companies

Some of the prominent players in the ligation devices market are are Ethicon (Johnson and Johnson) (US), Teleflex Incorporated (US), Olympus (Japan), Applied Medical (US), ConMed (US), Cooper Surgical (US), Genicon (US), Grena Think Medical (UK), B.Braun (Germany), and Medtronic (Ireland).

Johnson & Johnson (Ethicon) is the largest player in the ligation devices market. The company focuses on the development of devices, consumables, accessories, and software required to perform minimally invasive surgeries and open surgeries. The company also invests a significant amount on research and development activities. In 2018, it spent ~7% of its revenue on R&D activities.

Medtronic (Covidien) is a major player in the ligation devices market. The company has a global distribution network and a good brand reputation among end users. The company’s strong presence and wide distribution channels across the globe have helped it to maintain its leading position in the ligation devices market.

Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=22007372

Increasing privatization in the healthcare sector, poor reimbursement scenario for various medical treatments, large patient population base, and presence of a large number of hospitals/clinics with budget constraints in developing countries are the major factors driving the growth of this market. Growing initiatives undertaken by leading market players (such as GE Healthcare, Philips Healthcare, and Siemens Healthineers) to establish refurbishment facilities in both mature and developing markets are further adding to the growth prospects of Refurbished Medical Equipment market.

The refurbished medical equipment market is expected to reach USD 11.91 Billion by 2021 from USD 6.55 Billion in 2016, at a CAGR of 12.7% during the forecast period.

Emerging markets including India offer high growth potential for companies engaged in the development and distribution of refurbished medical devices. Growing initiatives by market players, increasing patient population base, and rising number of partnerships and agreements among OEMs and third-party refurbishers are the key factors propelling the growth of refurbished medical equipment market in emerging markets.

Target Audience:

• Original Equipment Manufacturers (OEMs)
• Third-party Refurbishers/Suppliers
• Hospitals
• Clinical Centers
• Group Purchasing Organizations (GPOs)
• Medical Research Laboratories
• Academic Medical Centers and Universities

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the refurbished medical equipment market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each product in emerging nations. The report provides qualitative insights about growth rates and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=770

GE Healthcare (U.K.), Philips Healthcare (Netherlands), and Siemens Healthineers (Germany), Agito Medical A/S (Denmark), Block Imaging International, Inc. (U.S.), DRE Medical, Inc. (U.S.), Radiology Oncology Systems, Inc., (U.S.) Soma Technology, Inc. (U.S.), Everx Pvt Ltd. (Australia), and Integrity Medical Systems, Inc. (U.S.) are some of the key players in the refurbished medical equipment market.

Global prevalence of peripheral artery diseases, increasing geriatric population, and rising prevalence of diabetes. On the other hand, the availability of alternative treatments and product failures and recalls are the major factors that are expected to restrain the growth of this market.

The peripheral vascular devices market is projected to reach USD 14.4 billion by 2024 from USD 10.3 billion in 2019, at a CAGR of 6.8%.

Catheters market is segmented into angiography catheters, guiding catheters, and IVUS/OCT catheters. In 2018, the angiography catheters segment accounted for the largest share of the catheters market. This is mainly due to the high and increasing prevalence of peripheral vascular diseases, coupled with the increasing awareness about the benefits of the early diagnosis of PVDs.

Peripheral vascular devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). While North America dominated the market in 2018, Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC market is largely driven by the large patient population and increasing focus of major players on this region.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790

Key Market Players

Prominent players in the peripheral vascular devices market are Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).